IND Approval
ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten
Precigen ActoBio
PR-M09-19-NI-006Sep 04, 2019
Celiac Disease
Amgen and Provention Bio Announce Co-Development Collaboration In Celiac Disease
Amgen
PR-M11-18-NI-018Nov 06, 2018